missing translation for 'onlineSavingsMsg'
Learn More

Tocris Bioscience™ Favipiravir

Numéro de catalogue. 722550
Change view
Click to view available options
Quantity:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantity
722550 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Numéro de catalogue. 722550 Fournisseur Tocris Bioscience™ Code fournisseur 7225/50
Il en reste null

Viral RNA polymerase inhibitor

Favipiravir is a viral RNA polymerase inhibitor; exhibits no effects on mammalian RNA polymerase. Prodrug that is phosphoribosylated by cellular enzymes to its active form, Favipiravir-ribofuranosyl-5'-triphosphate (RTP). Reduces infection rate of SARS-CoV-2 in Vero E6 cells in vitro (IC50 = 61.88 μM). Inhibits influenza virus RNA-dependent RNA polymerase (RdRP) activity (IC50 = 341 nM). Induces lethal mutagenesis in MDCK cells inoculated with seasonal influenza A (H1N1) viruses. Protects mice against Ebola virus.

Spécifications

Chemical Name or Material 6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide
CAS 259793-96-9
Quantity 50 mg
Target RNA/DNA Polymerase Inhibitors
Molecular Formula C5H4FN3O2
Purity 0.98